IQVIA Pharma Deals Review
ISSN 1756-7874. The business journal providing incisive analysis and expert opinion on the major deals.
Pharma Deals Review Latest Articles
-
Johnson & Johnson Pays Sail Biomedicines US$785M Upfront to Develop In Vivo CAR-T Therapies for Autoimmune Disease
-
Vertex Signs Multispecific T-Cell Engager Collaboration with AbCellera for Autoimmune Diseases
-
Innovent Signs US$1.1B Licensing Alliance with Spero for IBI355 (SP001), for the Teatment Immune-Mediated Diseases
-
Argenx to Acquire Forte Biosciences for US$2.2 B
-
Novartis Expands Oncology Portfolio with US$1.5 B Acquisition of Myricx
You can click on any of the bars to open a new page with the corresponding deals.
RSS